|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 11 July 2006
doi: 10.1242/jcs.03031
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
Virology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuohku, Tokyo 104-0045, Japan
* Author for correspondence (e-mail: mafujita{at}gan2.res.ncc.go.jp)
Accepted 3 May 2006
The activity of human Cdt1 is negatively regulated by multiple mechanisms. This suggests that Cdt1 deregulation may have a deleterious effect. Indeed, it has been suggested that overexpression of Cdt1 can induce rereplication in cancer cells and that rereplication activates Ataxia-telangiectasia-mutated (ATM) kinase and/or ATM- and Rad3-related (ATR) kinase-dependent checkpoint pathways. In this report, we highlight a new and interesting aspect of Cdt1 deregulation: data from several different systems all strongly indicate that unregulated Cdt1 overexpression at pathophysiological levels can induce chromosomal damage other than rereplication in non-transformed cells. The most important finding in these studies is that deregulated Cdt1 induces chromosomal damage and activation of the ATM-Chk2 DNA damage checkpoint pathway even in quiescent cells. These Cdt1 activities are negatively regulated by cyclin A/Cdks, probably through modification by phosphorylation. Furthermore, we found that deregulated Cdt1 induces chromosomal instability in normal human cells. Since Cdt1 is overexpressed in cancer cells, this would be a new molecular mechanism leading to carcinogenesis.
Key words: Cdt1, Checkpoint, Chromosomal damage, Chromosomal instability
This article has been cited by other articles:
![]() |
E. M. N. Dohmann, M. P. Levesque, L. De Veylder, I. Reichardt, G. Jurgens, M. Schmid, and C. Schwechheimer The Arabidopsis COP9 signalosome is essential for G2 phase progression and genomic stability Development, June 1, 2008; 135(11): 2013 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sugimoto, I. Kitabayashi, S. Osano, Y. Tatsumi, T. Yugawa, M. Narisawa-Saito, A. Matsukage, T. Kiyono, and M. Fujita Identification of Novel Human Cdt1-binding Proteins by a Proteomics Approach: Proteolytic Regulation by APC/CCdh1 Mol. Biol. Cell, March 1, 2008; 19(3): 1007 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lau, T. Tsuji, L. Guo, S.-H. Lu, and W. Jiang The role of pre-replicative complex (pre-RC) components in oncogenesis FASEB J, December 1, 2007; 21(14): 3786 - 3794. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Liu, A. Y.-L. Lee, T. Chiba, E. Olson, P. Sun, and X. Wu The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted J. Cell Biol., November 19, 2007; 179(4): 643 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iwahori, N. Shirata, Y. Kawaguchi, S. K. Weller, Y. Sato, A. Kudoh, S. Nakayama, H. Isomura, and T. Tsurumi Enhanced Phosphorylation of Transcription Factor Sp1 in Response to Herpes Simplex Virus Type 1 Infection Is Dependent on the Ataxia Telangiectasia-Mutated Protein J. Virol., September 15, 2007; 81(18): 9653 - 9664. [Abstract] [Full Text] [PDF] |
||||